Literature DB >> 12499457

Update of predictions of mortality from pleural mesothelioma in the Netherlands.

O Segura1, A Burdorf, C Looman.   

Abstract

AIMS: To predict the expected number of pleural mesothelioma deaths in the Netherlands from 2000 to 2028 and to study the effect of main uncertainties in the modelling technique.
METHODS: Through an age-period-cohort modelling technique, age specific mortality rates and cohort relative risks by year of birth were calculated from the mortality of pleural mesothelioma in 1969-98. Numbers of death for both sexes were predicted for 2000 to 2028, taking into account the most likely demographic development. In a sensitivity analysis the relative deviation of the future death toll and peak death number were studied under different birth cohort risk assumptions.
RESULTS: The age-cohort model on mortality 1969-98 among men showed the highest age specific death rates in the oldest age group (79 per 100 000 person-years in the age group 80-84 years) and the highest relative risks for the birth cohorts of 1938-42 and 1943-47. Among men a small period effect was observed. The age-cohort model was considered the best model for predicting future mortality. The most plausible scenario predicts an increase in pleural mesothelioma mortality up to 490 cases per year in men, with a total death toll close to 12 400 cases during 2000-28. However, using different assumptions this death toll could rise to nearly 15 000 in men (20% increase). Mortality among women remains low, with a total death toll of about 800 cases. It is predicted that the total death toll in the period 2000-28 is 44% lower than previous predictions using mortality data from 1969 to 1993.
CONCLUSION: Adding five recent years of observed mortality in an age-cohort model resulted in a 44% lower prediction of the future death toll of pleural mesothelioma. A statistically significant period effect was observed, possibly influenced by initial asbestos safety guidelines in the 1970s and introduction of the ICD-10 codification.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499457      PMCID: PMC1740374          DOI: 10.1136/oem.60.1.50

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  21 in total

Review 1.  Understanding the effects of age, period, and cohort on incidence and mortality rates.

Authors:  T R Holford
Journal:  Annu Rev Public Health       Date:  1991       Impact factor: 21.981

Review 2.  Asbestos-related diseases.

Authors:  B T Mossman; J B Gee
Journal:  N Engl J Med       Date:  1989-06-29       Impact factor: 91.245

3.  A history of awareness of asbestos disease and the control of occupational asbestos exposures in The Netherlands.

Authors:  L Burdorf; P H Swuste; D Heederik
Journal:  Am J Ind Med       Date:  1991       Impact factor: 2.214

4.  Towards the coordination of European research on the carcinogenic effects of asbestos.

Authors:  P Boffetta; A Burdorf; M Goldberg; E Merler; J Siemiatycki
Journal:  Scand J Work Environ Health       Date:  1998-08       Impact factor: 5.024

Review 5.  Age-period-cohort analysis of chronic disease rates. I: Modelling approach.

Authors:  C Robertson; P Boyle
Journal:  Stat Med       Date:  1998-06-30       Impact factor: 2.373

6.  Analysis of current trends in United States mesothelioma incidence.

Authors:  B Price
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

7.  Models for temporal variation in cancer rates. II: Age-period-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

8.  Analysis of cancer rates using excess risk age-period-cohort models.

Authors:  W C Lee; R S Lin
Journal:  Int J Epidemiol       Date:  1995-08       Impact factor: 7.196

9.  Pleural mesotheliomas are underreported as occupational cancer in Sweden.

Authors:  E Andersson; K Torén
Journal:  Am J Ind Med       Date:  1995-04       Impact factor: 2.214

10.  Continuing increase in mesothelioma mortality in Britain.

Authors:  J Peto; J T Hodgson; F E Matthews; J R Jones
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

View more
  21 in total

1.  [Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Pe'choux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-10

2.  Disease mapping of zero-excessive mesothelioma data in Flanders.

Authors:  Thomas Neyens; Andrew B Lawson; Russell S Kirby; Valerie Nuyts; Kevin Watjou; Mehreteab Aregay; Rachel Carroll; Tim S Nawrot; Christel Faes
Journal:  Ann Epidemiol       Date:  2016-11-01       Impact factor: 3.797

3.  Changing trends in US mesothelioma incidence.

Authors:  H Weill; J M Hughes; A M Churg
Journal:  Occup Environ Med       Date:  2004-05       Impact factor: 4.402

4.  Filing for workers' compensation among Ontario cases of mesothelioma.

Authors:  Jennifer Isabelle Payne; Erin Pichora
Journal:  Can Respir J       Date:  2009 Sep-Oct       Impact factor: 2.409

5.  Prediction of mesothelioma and lung cancer in a cohort of asbestos exposed workers.

Authors:  Antonio Gasparrini; Anna Maria Pizzo; Giuseppe Gorini; Adele Seniori Costantini; Stefano Silvestri; Cesare Ciapini; Andrea Innocenti; Geoffrey Berry
Journal:  Eur J Epidemiol       Date:  2008-04-26       Impact factor: 8.082

6.  Projected mesothelioma incidence in men in New South Wales.

Authors:  Mark Clements; Geoffrey Berry; Jill Shi; Sandra Ware; Deborah Yates; Anthony Johnson
Journal:  Occup Environ Med       Date:  2007-04-20       Impact factor: 4.402

Review 7.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

8.  Malignant pleural mesothelioma: an epidemiological perspective.

Authors:  Benjamin M Robinson
Journal:  Ann Cardiothorac Surg       Date:  2012-11

9.  Projection of mesothelioma mortality in Britain using Bayesian methods.

Authors:  E Tan; N Warren; A J Darnton; J T Hodgson
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

10.  Future Incidence of Malignant Mesothelioma in South Korea: Updated Projection to 2038.

Authors:  Kyeongmin Kwak; Sung-Il Cho; Domyung Paek
Journal:  Int J Environ Res Public Health       Date:  2021-06-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.